Abstract
Purpose
We compared the short-term visual outcomes of patients fitted with trifocal diffractive intraocular lenses (IOLs) and bifocal IOLs 3 months after IOL implantation.
Methods
We included 38 eyes undergoing IOL implantation at a single tertiary hospital. In all, 21 eyes received bifocal IOLs (TECNIS® 1 ZLB00; Abbott Medical Optics Inc., Santa Ana, CA, USA) and 17 received trifocal diffractive IOLs (FineVision® POD F; PhysIOL SA, Liège, Belgium). The primary outcomes were corrected and uncorrected visual acuities at 4 m, 50 cm, and 33 cm on postoperative weeks 1,4, and 12, and the spherical equivalence values at those times. The secondary outcomes included contrast sensitivity measured using an Optec 6500® instrument (Stereo Optical Co. Inc., Chicago, IL, USA) 4 weeks after surgery, the numbers of total and internal optical aberrations assessed using the iTrace® (Tracey Technologies, Houston, TX, USA) instrument at 12 weeks, symptoms including glare or halo, and the need for spectacles when engaging in daily activity.
Results
One week after surgery, eyes implanted with trifocal IOLs exhibited significantly better uncorrected near vision compared to eyes that had received bifocal IOLs, and at weeks 4 and 12, uncorrected intermediate vision was also better in the former eyes. The mean spherical equivalence did not significantly differ between the two groups, nor did the contrast sensitivity measured on postoperative week 4 or the numbers of optical aberrations evident at postoperative week 12. Eyes fitted with trifocal IOLs appeared to suffer less from glare or halo, but the between-group difference was not significant. The two groups did not significantly differ in terms of the need to wear supplementary spectacles.
REFERENCES
1). de Silva SR, Evans JR, Kirthi V, et al. Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database Syst Rev. 2016; 12:CD003169. DOI: 10.1002/14651858.CD003169. pub4.
2). Kook D, Kampik A, Dexl AK, et al. Advances in lens implant technology. F1000 Med Rep. 2013; 5:3.
3). Cochener B, Lafuma A, Khoshnood B, et al. Comparison of outcomes with multifocal intraocular lenses: a meta-analysis. Clin Ophthalmol. 2011; 5:45–56.
4). Gatinel D, Pagnoulle C, Houbrechts Y, Gobin L. Design and qualification of a diffractive trifocal optical profile for intraocular lenses. J Cataract Refract Surg. 2011; 37:2060–7.
5). Fell-Carlson D. Working Safely in Health Care: a Practical Guide. 1st. New York: Delmar Cengage Learning;2007. p. 77.
6). Evans JR, Fletcher AE, Wormald RP; MRC Trial of Assessment and Management of Older People in the Community. Causes of visual impairment in people aged 75 years and older in Britain: an add-on study to the MRC Trial of Assessment and Management of Older People in the Community. Br J Ophthalmol. 2004; 88:365–70.
7). Kim C, Kwon JW, Wee WR, et al. Factors affecting the visual outcome of cataract surgery in the very elderly. J Korean Ophthalmol Soc. 2007; 48:905–10.
8). Allen ED, Burton RL, Webber SK, et al. Comparison of a diffractive bifocal and a monofocal intraocular lens. J Cataract Refract Surg. 1996; 22:446–51.
9). Steinert RF, Post CT Jr, Brint SF, et al. A Prospective, randomized, double-masked comparison of a zonal-progressive multifocal intraocular lens and a monofocal intraocular lens. Ophthalmology. 1992; 99:853–60. discussion 860-1.
10). Cochener B, Vryghem J, Rozot P, et al. Clinical outcomes with a trifocal intraocular lens: a multi-center study. J Refract Surg. 2014; 30:762–8.
11). Postolache C, Postolache O. Comparation of refractive results with bifocal implants AT LISA 809 and trifocal AT LISA TRI839. Rom J Ophthalmol. 2015; 59:100–2.
12). Mojzis P, Kukuckova L, Majerova K, et al. Comparative analysis of the visual performance after cataract surgery with implantation of a bifocal or trifocal diffractive IOL. J Refract Surg. 2014; 30:666–72.
13). Gatinel D, Houbrechts Y. Comparison of bifocal and trifocal diffractive and refractive intraocular lenses using an optical bench. J Cataract Refract Surg. 2013; 39:1093–9.
14). Mojzis P, Peña-García P, Liehneova I, et al. Outcomes of a new diffractive trifocal intraocular lens. J Cataract Refract Surg. 2014; 40:60–9.
15). Vryghem JC, Heireman S. Visual performance after the implantation of a new trifocal intraocular lens. Clin Ophthalmol. 2013; 7:1957–65.
16). Jonker SM, Bauer NJ, Makhotkina NY, et al. Comparison ofa trifocal intraocular lens with a +3.0 D bifocal IOL: results of a prospective randomized clinical trial. J Cataract Refract Surg. 2015; 41:1631–40.
17). Lee H, Lee K, Ahn JM, et al. Evaluation of optical quality parameters and ocular aberrations in multifocal intraocular lens implanted eyes. Yonsei Med J. 2014; 55:1413–20.
18). Jun I, Choi YJ, Kim EK, et al. Internal spherical aberration by ray tracing-type aberrometry in multifocal pseudophakic eyes. Eye (Lond). 2012; 26:1243–8.
19). Kim JS, Jung JW, Lee JM, et al. Clinical outcomes following implantation of diffractive multifocal intraocular lenses with varying add powers. Am J Ophthalmol. 2015; 160:702–9.e1.
20). Dick HB, Krummenauer F, Schwenn O, et al. Objective and subjective evaluation of photic phenomena after monofocal and multifocal intraocular lens implantation. Ophthalmology. 1999; 106:1878–86.
Table 1.
Bifocal intraocular lens | Trifocal intraocular lens | p-value* | |
---|---|---|---|
Number of eyes (patients) | 21 (14) | 17 (11) | |
Right eye:Left eye | 12:9 | 7:10 | |
Ages (years) | 58.53 ± 10.68 | 63.17 ±7.36 | 0.21 |
UCDVA (logMAR) | 0.41 ±0.35 | 0.42 ± 0.26 | 0.94 |
SE (D) | −0.30 ± 2.30 | −0.44 ± 2.56 | 0.88 |
Mean K (D) | 44.02 ± 0.97 | 43.82 ± 1.19 | 0.65 |
Axial length (mm) | 23.75 ±0.73 | 23.65 ± 1.02 | 0.77 |
ACD (mm) | 3.38 ±0.29 | 3.23 ± 0.44 | 0.32 |
IOL power (D) | 20.20 ± 2.08 | 19.67 ± 2.42 | 0.54 |
Table 2.
1 week |
1 month |
3 months |
|||||||
---|---|---|---|---|---|---|---|---|---|
Bifocal intraocular lens | Trifocal intraocular lens | p-value* | Bifocal intraocular lens | Trifocal intraocular lens | p-value* | Bifocal intraocular lens | Trifocal intraocular lens | p-value* | |
UCDVA (logMAR) | 0.09 ± 0.11 | 0.12 ± 0.11 | 0.45 | 0.07 ± 0.08 | 0.11 ± 0.14 | 0.36 | 0.07 ± 0.07 | 0.07 ± 0.12 | 0.86 |
CDVA (logMAR) | 0.03 ± 0.05 | 0.02 ± 0.02 | 0.22 | 0.02 ± 0.04 | 0.03 ± 0.05 | 0.68 | 0.02 ± 0.04 | 0.03 ± 0.06 | 0.91 |
UCIVA (logMAR) | 0.16 ± 0.10 | 0.18 ± 0.11 | 0.58 | 0.19 ± 0.10 | 0.12 ± 0.08 | 0.04 | 0.18 ± 0.08 | 0.08 ± 0.12 | 0.02 |
UCNVA (logMAR) | 0.18 ± 0.06 | 0.10 ± 0.07 | <0.01 | 0.12 ± 0.09 | 0.08 ± 0.10 | 0.26 | 0.13 ± 0.10 | 0.08 ± 0.03 | 0.17 |
S.E (D) | −0.12 ± 0.33 | −0.22 ± 0.40 | 0.46 | −0.28 ± 0.41 | −0.22 ± 0.45 | 0.68 | −0.22 ± 0.35 | −0.22 ± 0.40 | 0.99 |
Table 3.
Parameter (μM) | Bifocal intraocular lens | Trifocal intraocular lens | p-value* |
---|---|---|---|
RMS total | 0.57 ± 0.27 | 0.64 ± 0.29 | 0.48 |
Total HOA | 0.37 ± 0.22 | 0.37 ± 0.23 | 0.93 |
Coma | 0.18 ± 0.12 | 0.15 ± 0.09 | 0.55 |
Spherical | −0.05 ± 0.10 | −0.06 ± 0.09 | 0.71 |
Trefoil | 0.17 ± 0.12 | 0.18 ± 0.12 | 0.72 |
Table 4.
Bifocal intraocular lens | Trifocal intraocular lens | p-value* | |
---|---|---|---|
Glare | 26.7 (4) | 17.6 (3) | 0.28 |
Halo | 33.3 (10) | 17.6 (3) | 0.16 |
Needs of spectacles | |||
For near | 9.5 (2) | 0 (0) | 0.20 |
For intermittent | 0 (0) | 0 (0) | - |
For distance | 4.8 (1) | 5.9 (1) | 0.88 |